Maltais f et al. adv ther. 2019 36:2434–2449
WebAdv Ther. 2024 Sep;36(9):2351-2363. doi: 10.1007/s12325-019-01030-4. Epub 2024 Jul 16. Authors Jonathan E Simons 1 , Elena B Mann 2 , Adam Pierozynski 2 Affiliations 1 Cello Health Insight, 11-13 Charterhouse Buildings, London, EC1M 7AP, UK. [email protected]. 2 Cello Health Insight, 11-13 Charterhouse ... Web14 dec. 2024 · The outcomes that were compared in Proskorovsky et al. included CR or CR with incomplete hematologic recovery (CR/CRi), HSCT, OS, and EFS. The definition of CRi was inconsistent between the two trials. In INO-VATE-ALL, CRi was defined as CR except with absolute neutrophil counts (ANC) < 1000/μL and/or platelet ≤ 100,000/μL.
Maltais f et al. adv ther. 2019 36:2434–2449
Did you know?
WebMaltais F et al Adv Ther 2024; 36:2434-2449 Feldman G Adv Ther 2024 34:2518-2533 Feldman GJ et al Int J Chron Obstruct Pulmon Dis 2016: 11:719-730 Certification of … Web11 dec. 2024 · Ther Adv Respir Dis. 2024;12:1–13. Article CAS Google Scholar Maltais F, Aumann JL, Kirsten A-M, et al. Dual bronchodilation with tiotropium/olodaterol further reduces activity-related breathlessness versus tiotropium alone in COPD. Eur Respir J. 2024;53(3):1802049.
Web2 jul. 2024 · Maltais, F., Ferguson, G.T., Feldman, G.J. et al. A Randomized, Double-Blind, Double-Dummy Study of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler … Web26 apr. 2016 · The most common adverse reactions with BEVESPI (≥2% and more common than placebo) were: cough, 4.0% (2.7%), and urinary tract infection, 2.6% (2.3%). Use …
Web17 aug. 2024 · Dear Editor, Lack of adherence to medications is frequent in chronic diseases and has important implications with regard to health outcomes, including an increased risk for poor clinical outcomes, mortality, and greater health care costs [1–3].As a high percentage of non-adherent patients are intentional, a strong belief in the necessity … Web29 okt. 2024 · 荟萃分析显示,双支扩中,乌美溴铵/维兰特罗对FEV1谷值的改善更佳. 一项纳入26项研究的荟萃分析,比较不同LAMA/LABA和噻托溴铵单药治疗24周后FEV1(第1 …
WebAdv Ther (2024) 36:2910–2926 2911. Due to the increased CV risk in the IPF patient population and its correlation with mortality, understanding the impact of IPF treatment on CV and bleeding events in patients with IPF is critical. This analysis examined whether pirfenidone treatment
Web1 aug. 2024 · 291/809 (36) 1.49 (1.22, ... Reproduced from Bjermer LH et al. Adv Ther 2024; 38:4815–35. https: ... (Maltais F et al. Respir Res 2024; 20 :238), we present an overview of valuable data from post hoc analyses and an original discussion of the clinical implications of these findings. the dark crystal age of resistance seriesWeb30 okt. 2024 · Background: Prospective evidence is lacking regarding incremental benefits of long-acting dual- versus mono-bronchodilation in improving symptoms and preventing … the dark crystal magicWeb8 jan. 2024 · A total of 22 studies involving 16,486 participants were included in this study. The results showed that in terms of primary outcome (change from baseline in trough FEV 1), the efficacy of vilanterol/umeclidinium was the highest, while the efficacy of formoterol/aclidinium was the lowest, with a maximum effect value (E max) of 0.185 L … the dark crystal movie online